QT interval prolongation and arrhythmia: an unbreakable connection?
1Department of Cardiovascular Medicine, Vanderbilt University Medical School, Nashville, TN, USA. mark.anderson@vanderbilt.edu
QT interval prolongation can increase arrhythmia risk, yet also serve as an antiarrhythmic strategy. Calmodulin kinase II (CaMKII) activation downstream of QT prolongation contributes to proarrhythmia, suggesting CaMKII inhibition as a therapeutic target.
Area of Science:
- Cardiology
- Molecular Biology
- Pharmacology
Background:
- QT interval prolongation is linked to arrhythmia risk but also used therapeutically.
- The precise cellular mechanisms underlying QT prolongation's proarrhythmic effects remain incompletely understood.
Purpose of the Study:
- To investigate the role of calmodulin kinase II (CaMKII) in the proarrhythmic consequences of QT interval prolongation.
- To explore CaMKII as a potential therapeutic target for managing arrhythmias associated with QT prolongation.
Main Methods:
- Cellular electrophysiology studies examining action potential duration and Ca2+ signaling.
- In vivo arrhythmia models to assess the impact of CaMKII inhibition.
Main Results:
- QT interval prolongation activates CaMKII, a specific cellular proarrhythmic signal.
- Inhibition of CaMKII prevents arrhythmia surrogates and in vivo arrhythmias linked to excessive action potential prolongation.
Conclusions:
- QT interval prolongation alone does not fully explain proarrhythmia; CaMKII activation is a key downstream mediator.
- CaMKII plays a significant role in the proarrhythmic effects of excessive QT prolongation, indicating its potential as a therapeutic target.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias II: Classification of Tachyarrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias


